{"id":10,"date":"2014-06-20T20:45:07","date_gmt":"2014-06-20T17:45:07","guid":{"rendered":"http:\/\/localhost\/tecimer\/?page_id=10"},"modified":"2014-10-10T15:40:29","modified_gmt":"2014-10-10T12:40:29","slug":"ozgecmis","status":"publish","type":"page","link":"https:\/\/coskuntecimer.com\/t\/ozgecmis","title":{"rendered":"\u00d6zge\u00e7mi\u015f"},"content":{"rendered":"
\"Prof.Dr.Coskun<\/a>

Prof.Dr.Coskun Tecimer<\/p><\/div>\n

1957 y\u0131l\u0131nda do\u011fdum. 1974 y\u0131l\u0131nda Ankara Mustafa Kemal Lisesini bitirdikten sonra \u00dcniversiteler Aras\u0131 Se\u00e7me S\u0131nav\u0131nda T\u00fcrkiye 11.si olarak Hacettepe T\u0131p Fak\u00fcltesi\u2019ne girdim. 1981 y\u0131l\u0131nda bu fak\u00fclteden mezun oldum.
\nAskerlik hizmetini tamamlad\u0131ktan sonra 1983 y\u0131l\u0131nda ayn\u0131 fak\u00fcltenin \u0130\u00e7 Hastal\u0131klar\u0131 Ana Bilim Dal\u0131\u2019na ara\u015ft\u0131rma g\u00f6revlisi olarak girdim. 1987 y\u0131l\u0131nda \u0130\u00e7 Hastal\u0131klar\u0131 uzman\u0131 oldum.
\n1990 y\u0131l\u0131nda 4 ay s\u00fcreyle \u0130ngiltere\u2019de Londra \u00dcniversitesi Royal Postgraduate Medical School Hematoloji B\u00f6l\u00fcm\u00fc\u2019nde, Finlandiya\u2019da Helsinki ve Kuopio \u00dcniversiteleri \u0130\u00e7 Hastal\u0131klar\u0131 Hematoloji B\u00f6l\u00fcmleri\u2019nde \u00e7al\u0131\u015ft\u0131m.
\nHaziran 1991 tarihinde \u0130n\u00f6n\u00fc \u00dcniversitesi T\u0131p Fak\u00fcltesi \u0130\u00e7 Hastal\u0131klar\u0131 Anabilim Dal\u0131\u2019na \u00f6\u011fretim g\u00f6revlisi olarak atand\u0131m.
\n1993 y\u0131l\u0131nda \u0130\u00e7 Hastal\u0131klar\u0131 do\u00e7enti oldum.
\n\u0130n\u00f6n\u00fc \u00dcniversitesi T\u0131p Fak\u00fcltesi\u2019nde bulundu\u011fum s\u00fcre i\u00e7inde \u0130\u00e7 Hastal\u0131klar\u0131 Anabilim Dal\u0131 Ba\u015fkanl\u0131\u011f\u0131, Dahili T\u0131p Bilimleri B\u00f6l\u00fcm Ba\u015fkan Vekilli\u011fi yapt\u0131m. T\u0131p Fak\u00fcltesi Hastanesi Hemodiyaliz ve Koroner Bak\u0131m \u00dcnitelerini ve Hematoloji Laboratuar\u0131n\u0131 kurdum. 1991-1992 ve 1992-1993 \u00f6\u011fretim y\u0131llar\u0131nda D\u00f6nem IV Koordinat\u00f6rl\u00fc\u011f\u00fc yapt\u0131m.<\/p>\n

1994 y\u0131l\u0131nda Marmara \u00dcniversitesi Hematoloji B\u00f6l\u00fcm\u00fc\u2019nde \u00fcst ihtisasa ba\u015flad\u0131m. Burada 1,5 y\u0131l \u00e7al\u0131\u015ft\u0131ktan sonra Amerika Birle\u015fik Devletleri\u2019ne gittim. Louisville \u00dcniversitesi James Graham Brown Kanser Merkezi Hematoloji-Onkoloji B\u00f6l\u00fcm\u00fc\u2019nde 3 y\u0131l resmi olarak klinik \u201cfellow\u201d olarak \u00e7al\u0131\u015ft\u0131m.
\n1999 y\u0131l\u0131 ba\u015flar\u0131nda T\u00fcrkiye\u2019ye d\u00f6nerek gerekli tez ve s\u0131navlar\u0131 tamamlayarak hem Hematoloji, hem de T\u0131bbi Onkoloji\u2019de \u00fcst ihtisas uzmanl\u0131klar\u0131n\u0131 ald\u0131m.
\n2000 y\u0131l\u0131nda Kadir Has \u00dcniversitesi T\u0131p Fak\u00fcltesi \u0130\u00e7 Hastal\u0131klar\u0131 Anabilim Dal\u0131\u2019na profes\u00f6r olarak atand\u0131m.
\n2006 y\u0131l\u0131nda da \u0130stanbul Bilim \u00dcniversitesi T\u0131bbi Onkoloji B\u00f6l\u00fcm\u00fcn\u00fc kurdum. Halen bu \u00fcniversitenin T\u0131bbi Onkoloji Bilim Dal\u0131 Ba\u015fkanl\u0131\u011f\u0131\u2019n\u0131 y\u00fcr\u00fctmekte ve Metropolitan Florence Nightingale Hastanesi Hematoloji \u2013 Onkoloji b\u00f6l\u00fcm\u00fcnde profes\u00f6r doktor olarak \u00e7al\u0131\u015fmaktay\u0131m.
\nYerli ve yabanc\u0131 \u00e7ok say\u0131da t\u0131bbi yay\u0131n\u0131m ve yazd\u0131\u011f\u0131m kitap b\u00f6l\u00fcm\u00fc vard\u0131r. Ayr\u0131ca Cumhuriyet ve Radikal gazetelerinde t\u0131bbi ve t\u0131p d\u0131\u015f\u0131 konularda yay\u0131nlanm\u0131\u015f makalelerim bulunmaktad\u0131r. Bir\u00e7ok di\u011fer gazete, g\u00f6rsel medya ve internet sitelerinde yay\u0131nlanm\u0131\u015f r\u00f6portajlar\u0131m vard\u0131r. Evli ve iki \u00e7ocukluyum. \u0130yi derecede \u0130ngilizce bilirim.<\/p>\n

\u00d6zge\u00e7mi\u015f<\/strong><\/p>\n

\n\n\n\n\n
Ad\u0131 Soyad\u0131<\/td>\nCo\u015fkun Tecimer<\/td>\n <\/td>\n<\/tr>\n
Do\u011fum Tarihi<\/td>\n24 \/ 6 \/ 1957<\/td>\n <\/td>\n<\/tr>\n
\u00dcnvan\u0131<\/td>\nProfes\u00f6r<\/td>\n <\/td>\n<\/tr>\n<\/table>\n<\/div>\n

\u00d6\u011frenim Durumu:<\/strong><\/p>\n

\n\n\n\n\n\n\n
Derece<\/strong><\/td>\nAlan<\/strong><\/td>\n\u00dcniversite<\/strong><\/td>\nY\u0131l<\/strong><\/td>\n <\/td>\n<\/tr>\n
Lisans<\/td>\nT\u0131p<\/td>\nHacettepe \u00dcniversitesi<\/td>\n1981<\/td>\n <\/td>\n<\/tr>\n
Uzmanl\u0131k<\/td>\n\u0130\u00e7 Hastal\u0131klar\u0131<\/td>\nHacettepe \u00dcniversitesi<\/td>\n1987<\/td>\n <\/td>\n<\/tr>\n
Yan Dal Uzmanl\u0131k<\/td>\nT\u0131bbi Onkoloji<\/td>\nMarmara \u00dcniversitesi<\/td>\n1999<\/td>\n <\/td>\n<\/tr>\n
Yan Dal Uzmanl\u0131k<\/td>\nHematoloji<\/td>\nMarmara \u00dcniversitesi<\/td>\n1999<\/td>\n <\/td>\n<\/tr>\n<\/table>\n<\/div>\n

Akademik \u00dcnvanlar:<\/strong><\/p>\n

\n\n\n\n\n
Yard\u0131mc\u0131 Do\u00e7entlik Tarihi<\/td>\nKas\u0131m 1991<\/td>\n <\/td>\n <\/td>\n <\/td>\n <\/td>\n<\/tr>\n
Do\u00e7entlik Tarihi<\/td>\n 12 Ekim 1993<\/td>\n <\/td>\n <\/td>\n <\/td>\n <\/td>\n<\/tr>\n
Profes\u00f6rl\u00fck Tarihi<\/td>\n21 Haziran 2000<\/td>\n <\/td>\n <\/td>\n <\/td>\n <\/td>\n<\/tr>\n<\/table>\n<\/div>\n

Y\u00f6netilen Y\u00fcksek Lisans ve Doktora Tezleri<\/strong><\/p>\n

1. Doktora Tezleri: \u015eu anda G\u0130S kanserleriyle ilgili Onkolojide proje a\u015famas\u0131nda.<\/p>\n

 
\nYay\u0131nlar:<\/strong><\/p>\n

1. Uluslararas\u0131 hakemli dergilerde yay\u0131nlanan makaleler (SCI, SSCI, Arts and Humanities)<\/strong><\/p>\n

1- Tecimer C, Oram Y, Tecimer T. Lupus vulgaris in a patient with pulmonary tuberculosis. Cutis 1994; 53:246-8.
\n2- Tecimer C, Yam LT. Surreptitious superwarfarin poisoning with brodifacoum. Southern Medical Journal 1997; 90:1053-5.
\n3- Tecimer C, Loy BA, Martin AW. Acute myeloblastic leukemia (M0) with an unusual chromosomal abnormality: Translocation (1;14) (p13;q32). Cancer Genetics and Cytogenetics 1999; 111:175-7.
\n4- Tecimer C, Doering D, Abdulhay G, Goldsmith J, Meyer JS, Wittliff JL. Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer. International Journal of Gynecological Cancer 2000; 10:372-81.
\n5- Tecimer C, Doering D, Abdulhay G, Goldsmith J, Meyer JS, Wittliff JL. Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in endometrial cancer. Gynecologic Oncology 2001; 80:48-55.
\n6- Al\u00e7o G, \u0130\u011fdem \u015e, Din\u00e7er M, Tecimer C, \u015eent\u00fcrk R, Vural M, Okkan S. Gemcitabine induced radiation recall myositis: Report of two cases. International Journal of Hematology and Oncology 2009; 19: 249-253.<\/p>\n

2. Uluslararas\u0131 di\u011fer hakemli dergilerde yay\u0131nlanan makaleler (SCI Expanded)<\/strong><\/p>\n

1- Akun E, Okutur K, Seber S, Korkmaz T, Ayd\u0131n K, Bozkurt M, Namal E, Hasbal B, Tecimer C, Demir G. Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer. Journal of Balkan Union of Oncology 2012; 17: 669-76.
\n2- Pilanc\u0131 KN, Elb\u00fcken F, Ordu \u00c7, K\u00f6ksal G, Tekelio\u011flu MH, Okutur K, G\u00f6ksel S, K\u00f6ksal \u00dc, Ak\u00e7al T, Tecimer C. A case of sunitinib induced hyperammonemic encephalopathy and hypothyroidism in metastatic renal cell carcinoma. American Journal of Theapeutics (in press)<\/p>\n

3. Uluslararas\u0131 bilimsel toplant\u0131larda sunulan ve bildiri kitab\u0131nda (Proceedings) bas\u0131lan bildiriler<\/strong><\/p>\n

1- Oto A, Tecimer C, Oram E, U\u011furlu \u015e, Karamehmeto\u011flu A, Oram A. Disturbance in the autonomic control of the heart rate in patients with acute myocardial infarction. Mediterranean Association of Cardiology and Cardiac Surgery 1st Annual Meeting, Cavtat-Dubrovnic Yugoslavia, October 8-11, 1987. Abstracts, 199.
\n2- Alpdo\u011fan O, Budak-Alpdo\u011fan T, Tanr\u0131verdi S, Tecimer C, F\u0131ratl\u0131-Tu\u011flular T, Bay\u0131k M, Ako\u011flu T. The efficacy of mega-dose methylprednisolon treatment in patients with idiopathic thrombocytopenic purpura. The 13th Meeting of the International Society of Haematology (European and African Division), \u0130stanbul, September 3-8, 1995. Abstract Book, Abstract No: 697.
\n3- Tecimer C, Bhupalam L, Djulbegovic B. Is standard heparin superior to low molecular weight heparin in malignancy related deep vein thrombosis? The 39th Annual Meeting of the American Society of Hematology, San Diego, CA, December 5-9, 1997. Blood 1997; 90: 124b.
\n4- Wittliff JL, Smolenkov AS, Tecimer C, Schmitt GA, Tuckson WB, Galandiuk S.
\nExpression of urokinase-type plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1) in Russian and American patients with colon carcinoma. The Meeting of the Clinical Ligand Assay Society, New York, NY, Spring 1998. J Clin Ligand Assay 1998; 21: 87.
\n5- Tecimer C, Doering DL, Meyer JS, Abdulhay G, Goldsmith LJ, Wittliff JL. Prognostic significance of uPA, uPAR and PAI-1 expression in the management of endometrial cancer. The 35th Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA, May 15-18, 1999. Proceedings 1999; 18: 160a.
\n6- Dane F, Yumuk PF, Turhal NS, Ekenel M, Ba\u015faran G, \u0130yikesici MS, Tecimer C. FOLFOX 4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU\/irinotecan based combination regimens. The 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, LA, June 5-8, 2004. J Clin Onc, 2004; 22: 301S.
\n7- \u0130\u011fdem \u015e, Alt\u0131n M, Al\u00e7o G, Ercan T, Kara B, \u00dcnalan B, Tecimer C, K\u00f6ksal G, Turkan S, Okkan S. PET\/CT guided, dose painting IMRT for nasopharyngeal carcinoma. Proceedings of the American Society for Therapeutic Radiology and Oncology 50th Meeting, 21-25 September, 2008 Boston, MA. Radiation Oncology Biology, Physics 2008; 72: S424-5.
\n8- Okutur K, Turan C, Tecimer C, Demir G. Toxicity of bevacizumab (BV) in metastatic colorectal cancer (MCRC): Data from clinical practice. 7th Congress of B.U.O.N., 16-19 October, 2008, \u0130zmir, Turkey. Journal of B.U.O.N. 2008; 13 (Suppl 1): S31.
\n9- Okutur K, Demir G, Tecimer C, Erdem L, Turan C. Toxicity of bevacizumab in metastatic colorectal cancer: Data from clinical practice. Poster presentation. 18th International Postgraduate Course of the International Association of Surgeons and Gastroenterologists and Oncologists, October 2008. Hepatogastroenterology Current Medical and Surgical Trends 2008; 55 (Suppl 1): S165-6.
\n10- Okutur K, Ayd\u0131n K, Bozkurt M, Turan C, Demir N, Hasbal B, Erdem L, Tecimer C, Demir G. Toxicity of bevacizumab in metastatic colorectal cancer: Data from clinical practice. 1st Congress of the Mediterranean Multidisciplinary Oncology Forum, 10-13 September 2009, Athens. Abstract 28.
\n11- \u0130\u011fdem \u015e, Alt\u0131n M, Al\u00e7o G, Ercan T, \u00dcnalan B, Tecimer C, K\u00f6ksal G, G\u00fcrses K, Demir G, Okkan S. Whole field simultaneous integrated boost IMRT in nasopharyngeal cancer. I J Radiation Oncology Biology Physics 2010; 78: S478.
\n12- Ba\u015faran G, Sa\u011flam S, Tansan S, Demirel M, G\u00f6kmen E, Aktan S, G\u00f6ker E, Kaban KK, Saip P, Demir G, Bavbek SE, Mandel NM, Tecimer C, Turhal NS, Garipo\u011flu M. The impact of 21-gene recurrence score (RS) scores on treatment decisions. Retrospective evaluation in Turkish early-stage breast cance (BC) patients. The 47th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, June 3-7, 2011. J Clin Onc, 2011; 29: Abstract No:e11042.
\n13- Bozkurt M, Okutur K, Ayd\u0131n K, Namal E, \u00d6zt\u00fcrk A, Tecimer C, Ak\u00e7al\u0131 Z, Demir G. The impact of early thromboembolic event on prognosis in cancer parients: A single-center analysis of 1838 patients. The 47th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, June 3-7, 2011. J Clin Onc, 2011; 29: Abstract No:e19694.
\n14- Pilanc\u0131 KN, Ordu \u00c7, Okutur K, \u0130ner Koksal \u00dc, Sa\u011flam S, Tecimer C, Demir G. 17. European Cancer Congress, Amsterdam, 27 September-1 October 2013.
\n15- Al\u00e7o G, \u0130\u011fdem \u015e, Din\u00e7er M, \u00d6zmen V, Demir G, K\u00f6ksal G, Tecimer C, Selamo\u011flu D, Pilanc\u0131 KN, Okkan S. Can megestrol acetate induce thrombosis in oncology patients? 17. European Cancer Congress, Amsterdam, 27 September-1 October 2013.<\/p>\n

4. Ulusal hakemli dergilerde yay\u0131nlanan makaleler <\/strong><\/p>\n

1- Oram A, Tecimer C, Oto A, Karamehmeto\u011flu A, Oram E, U\u011furlu S. Akut miyokard infarkt\u00fcs\u00fcnde kalbin otonom sinir sistemi taraf\u0131ndan kontrol\u00fcnde de\u011fi\u015fimler. Kardiyoloji 1988; 1:120-4.
\n2- Tecimer C. Kemik ili\u011fi transplantasyonu. T\u00fcrk \u0130la\u00e7 ve Tedavi Dergisi 1990; 3:528-30.
\n3- Tecimer C. Gastritis ve Tedavisi . T\u00fcrk \u0130la\u00e7 ve Tedavi Dergisi 1990; 3:585-91.
\n4- Durmaz R, Tecimer C, Durmaz B, Temel \u0130, G\u00fcnal S. Concurrent hepatitis B surface antigen and antibody. Do\u011fa Tr J of Medical Sciences 1992; 16:785-9.
\n5- Tecimer C, Pehlivan E. Enalapril ve kaptoprilin antihipertansif etkilerinin ara\u015ft\u0131r\u0131lmas\u0131. T\u00fcrk \u0130la\u00e7 ve Tedavi Dergisi 1992; 5:552-8.
\n6- Tecimer C, Ayd\u0131n EE, Pehlivan E. H2-resept\u00f6r antagonistlerinden ranitidin ve famotidinin doodenal \u00fclser tedavisinde etkilerinin ara\u015ft\u0131r\u0131lmas\u0131. T\u00fcrk \u0130la\u00e7 ve Tedavi Dergisi 1992; 5:620-4.
\n7- Tecimer C, Durmaz R, Durmaz B, Temel \u0130, Ozdemir R. Akut hepatit B infeksiyonundan sonra uzam\u0131\u015f anti-HBc IgM pozitifli\u011finin anlam\u0131. Ege T\u0131p Dergisi 1992; 31:599-602.
\n8- Durmaz R, Tecimer C, Durmaz B, Gunal S, Temel \u0130, K\u0131z\u0131lkaya N. Anti-HCV positivity among different groups in Malatya, Turkey. \u0130nfeksiyon Dergisi 1992; 6:247-9.
\n9- Tecimer C, Durmaz R, Durmaz B, Temel \u0130, Alada\u011f M, Yolo\u011flu S. Malatya y\u00f6resinde hepatit B virus infeksiyonu. Gastroenterohepatoloji 1993; 4:61-6.
\n10- Tecimer C, Durmaz R, Durmaz B, Temel \u0130, G\u00fcnal S, Alada\u011f M. Hepatitis delta virus infection among the different groups in the region of Malatya. Gastroenteroloji 1993; 4:257-9.
\n11- Tecimer T, Tecimer C, Dursun A, Akyol G, Haznedar R, Atao\u011flu O, \u00dcst\u00fcn H, Alada\u011f M. De\u011fi\u015fik hematolojik hastal\u0131klarda kemik ili\u011fi retik\u00fclin d\u00fczeyi: 150 olgunun de\u011ferlendirilmesi. T.C.D.D. Hastaneleri T\u0131p B\u00fclteni 1993; 1:34-9.
\n12- Tecimer T, Tecimer C, Emre H, Temel \u0130, \u00dcst\u00fcn H, Karaka\u015f S, Otlu A, Erpek S. Aflatoksin B1 (AFB1)\u2019in tav\u015fan karaci\u011feri \u00fczerine etkileri: histopatolojik ve biyokimyasal de\u011ferlendirme. Ege T\u0131p Dergisi 1993; 32:45-8.
\n13- Tecimer C, \u00dcst\u00fcn M, Alada\u011f M, Ozdemir R, Yolo\u011flu S, Pehlivan E, \u00d6zdo\u011fan M, P\u0131nar T. Sigara ve yanmam\u0131\u015f t\u00fct\u00fcn\u00fcn hematolojik parametreler \u00fczerine etkileri. T\u00fcrk Hematoloji-Onkoloji Dergisi 1993; 3:75-84.
\n14- \u015eahin G, Milcan A, Tecimer C, K\u0131l\u0131\u00e7 A, \u015eahin B, Adezif kaps\u00fclit, diabetes mellitus ve Hba1c. Karadeniz T\u0131p Dergisi 1993; 6:187-9.
\n15- Tecimer C, Alada\u011f M, \u00d6zdemir R, \u00dcst\u00fcn M, Yolo\u011flu S, Pehlivan E, Ard\u0131\u00e7 S. Sigaran\u0131n akci\u011fer fonksiyonlar\u0131 \u00fczerine etkileri. Solunum Hastal\u0131klar\u0131 1993; 4:231-8.
\n16- Tecimer C, K\u0131z\u0131lkaya N, \u00d6zdemir R, Ak\u0131n O, Tayfun E, \u00dcst\u00fcn H, Hilmio\u011flu F, Y\u00fccesoy M. \u00d6zofagus Crohn hastal\u0131\u011f\u0131. Gastroenteroloji 1993; 4:534-5.
\n17- Durmaz B, Tecimer C, Durmaz R, K\u0131z\u0131lkaya N, Bozdemir F. Sigaran\u0131n serum IgA, IgG, ve IgM d\u00fczeylerine etkisi. Solunum Hastal\u0131klar\u0131 1993; 4:239-43.
\n18- Tecimer C, Oto A. Hasta sin\u00fcs sendromu ile ankilozan spondilitin birlikte g\u00f6r\u00fcld\u00fc\u011f\u00fc bir olgu. Kardiyoloji B\u00fclteni 1993; 2:14-6.
\n19- Tecimer C, Tecimer T, \u00dcst\u00fcn H, Erpek G, G\u00fcng\u00f6r S, Koral H, Bozk\u00fcrk S. \u0130nce i\u011fne aspirasyon biyopsisinin tiroid lezyonlar\u0131n\u0131n de\u011ferlendirilmesindeki yeri. Sel\u00e7uk \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi 1993; 9:183-90.
\n20- Tecimer C, Durmaz R, Durmaz B, Temel \u0130, G\u00fcnal S. Hepatit A: Klinik ve subklinik olgular. Atat\u00fcrk \u00dcniversitesi T\u0131p B\u00fclteni 1993; 25:61-5.
\n21- Tecimer C, Ard\u0131\u00e7 S, Pehlivan E, Yolo\u011flu S, \u00d6zdemir R, Alada\u011f M, \u00dcst\u00fcn M. Malatya Tekel t\u00fct\u00fcn fabrikas\u0131 i\u015f\u00e7ilerinde solunum fonksiyonlar\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131. \u0130non\u00fc \u00dcniversitesi Turgut \u00d6zal T\u0131p Merkezi Dergisi 1994; 1:141-8.
\n22- Tecimer C, Durmaz R, Durmaz B, Alada\u011f M, \u00d6zdemir R, G\u00fcnal S. Malatya\u2019da \u00e7e\u015fitli gruplarda \u201chuman immunodeficiency virus\u201d infeksiyonu. Osmangazi \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi 1994; 16:53-7.
\n23- Tecimer C, \u00dcst\u00fcn M, Alada\u011f M, \u00d6zdemir R, Yolo\u011flu S, Pehlivan S, Ard\u0131\u00e7 S. L\u00f6kosit ve trombosit say\u0131lar\u0131, sigara i\u00e7me ve akci\u011fer fonksiyonlar\u0131 aras\u0131ndaki ili\u015fki. T\u00fcberk\u00fcloz ve Toraks 1995; 43:203-8.
\n24- Tecimer C, \u00dcst\u00fcn H, G\u00fcng\u00f6r S, Koral H, G\u00f6nen S. Plevral eff\u00fczyon vakalar\u0131nda klinik ve sitopatolojik de\u011ferlendirme. Karadeniz T\u0131p Dergisi 1996; 7(Suppl):1-5.
\n25- \u00dcskent N, Demirba\u015f S, T\u00fcrken O, Y\u0131ld\u0131r\u0131m \u015e, Tecimer C, Kandemir G, Yaylac\u0131 M. Survival from the precocious brain metastasis of the colon cancer. The Turkish Journal of the Cancer 2003; 33: 154-157.
\n26- Breast Cancer Practice Pattern Study Group. Treatment approaches for metastatic breast cancer in Turkey. Turkish Journal of Cancer 2005; 35: 61-69.<\/p>\n

5. Ulusal bilimsel toplant\u0131larda sunulan ve bildiri kitab\u0131nda bas\u0131lan bildiriler<\/strong><\/p>\n

1- Tecimer C. Sinyal ileti inhibit\u00f6rleri. XIV. Ulusal Kanser Kongresi, \u0130stanbul, 30 Nisan-4 May\u0131s, 2001. Bildiri \u00d6zetleri Kitab\u0131 2001; sayfa 33.
\n2- Tecimer C. Kanser Hastalar\u0131nda Farmakolojik Destek Tedavileri. Onkoloji Hem\u015fireli\u011fi Hizmet \u0130\u00e7i E\u011fitim Kursu, Marmara \u00dcniversitesi T\u0131p Fak\u00fcltesi T\u0131bbi Onkoloji Bilim Dal\u0131, 3-6 Ekim, 2001, \u0130stanbul. 1. Cilt 2001; sayfa 87-92.
\n3- \u0130\u011fdem \u015e, Ercan T, Al\u00e7o G, Tecimer C, K\u00f6ksal G, Altun M, Turkan S, Okkan S. Yo\u011funluk ayarl\u0131 radyoterapi uygulanan ba\u015f-boyun kanserli olgularda akut yan etkiler. 17. Ulusal Kanser Kongresi, 19-23 Nisan, 2007, Antalya. Program ve Bildiri \u00d6zet Kitab\u0131 2007; sayfa 90.
\n4- \u0130\u011fdem \u015e, Al\u00e7o G, Ercan T, Tecimer C, K\u00f6ksal G, Altun M, Turkan S, Okkan S. Nazofarenks kanserinde yo\u011funluk ayarl\u0131 radyoterapi: Metropolitan Hastanesi deneyimi. 8. Ulusal Radyasyon Onkolojisi Kongresi, 19-23 Nisan 2008, Antalya. Bildiri Kitab\u0131; 2008; sayfa 78.
\n5- Okutur K, Ayd\u0131n KA, Demir N, Turan C, Tecimer C, Erdem L, Demir G. Metastatik kolorektal kanserde bevasizumab\u2019\u0131n toksisite profili. Poster sunusu. 18. Ulusal Kanser Kongresi, 21-26 Nisan 2009, Antalya. Program ve Bildiri \u00d6zet Kitab\u0131 2009; sayfa 85.
\n6- Okutur K, Ayd\u0131n K, Bozkurt M, Namal E, Demir N, Tecimer C, Demir G. Paraneoplastik dermatomiyozitle ba\u015fvuran iki k\u00fc\u00e7\u00fck h\u00fccreli akci\u011fer kanseri olgusu. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 30-1.
\n7- Okutur K, Ayd\u0131n K, Bozkurt M, Namal E, Halefo\u011flu AM, Tekelio\u011flu MH, Demir G, Tecimer C. K\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanserli bir hastada bevacizumab\u2019a ba\u011fl\u0131 intestinal perforasyon. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 31-2.
\n8- Okutur K, Ayd\u0131n K, Bozkurt M, Namal E, Kurt B, Demir G, Tecimer C. Metastazektomi ile uzun s\u00fcreli sa\u011fkal\u0131m sa\u011flanan akci\u011fer ve meme kanserli iki olgu. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 50-1.
\n9- Namal E, Hasbal B, Akman C, Okutur K, Ayd\u0131n K, Bozkurt M, Tecimer C, Demir G. Siklofosfamit ile ili\u015fkili akut solunum yetmezli\u011fi sendromu. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 51-2.
\n10- Okutur K, Ayd\u0131n K, Bozkurt M, Namal E, Halefo\u011flu AM, Tekelio\u011flu MH, Tecimer C, Demir G. Bevacizumaba ba\u011fl\u0131 intestinal perforasyon-vaka serisi. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 56-7.
\n11- Namal E, Hasbal B, \u0130\u015f\u00e7i H, Okutur K, Ayd\u0131n K, Bozkurt M, Tecimer C, Demir G. Atipik metastazlarla seyreden \u00fc\u00e7 meme kanseri olgusu. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 93.
\n12- Okutur K, Ayd\u0131n K, Bozkurt M, Namal E, Akman C, Mandel NM, Tecimer C, Demir G. Akci\u011fer metastazlar\u0131nda spontan regresyon g\u00f6r\u00fclen osteosarkom olgusu. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 100-1.
\n13- Okutur K, Ayd\u0131n K, Bozkurt M, Namal E, Kapran Y, Barlan M, Hasbal B, Tecimer C, Demir G. Patolojik ve klinik bir dilemma: intestinal berrak h\u00fccreli sarkom. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 103.
\n14- Okutur K, Dane F, \u0130lhan M, Seber S, Korkmaz T, Ayd\u0131n K, Bozkurt M, Namal E, Turhal S, Tecimer C, Demir G. Metastatik mide kanserinde haftal\u0131k dosetaksel, sisplatin, 5-florourasil rejiminin etkinli\u011fi ve g\u00fcvenilirli\u011fi. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 114.
\n15- Okutur K, Ayd\u0131n K, Bozkurt M, Namal E, Turan C, Do\u011fusoy GB, Tecimer C, Demir G. Kemoterapi uygulan\u0131rken yayg\u0131n cilt metastazlar\u0131 geli\u015fen mide kanserli bir olgu. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 115-6.
\n16- Ayd\u0131n K, Okutur K, Bozkurt M, Namal E, Giri\u015fken G, Ayd\u0131n \u00d6, Kuday C, Tecimer C, Demir G. Beyin tutulumuyla prezente olan bilateral primer adrenal non-Hodgkin lenfoma. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 135.
\n17- Hat\u0131rnaz T, Ko\u00e7 E, K\u0131l\u0131\u00e7 M, Okutur K, Tecimer C, Demir G. Adjuvan kemoterapi alan meme kanserli hastalar\u0131n beslenme al\u0131\u015fkanl\u0131klar\u0131 ve v\u00fccut a\u011f\u0131rl\u0131\u011f\u0131ndaki de\u011fi\u015fimler. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 140-1.
\n18- Hat\u0131rnaz T, Ko\u00e7 E, K\u0131l\u0131\u00e7 M, Okutur K, Tecimer C, Demir G. Epidermal b\u00fcy\u00fcme fakt\u00f6r\u00fc inhibit\u00f6r\u00fc tedavisi alan kanser hastalar\u0131nda cilt toksisitesi. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 141.
\n19- Hat\u0131rnaz T, Atay M, Ko\u00e7 E, K\u0131l\u0131\u00e7 M, Okutur K, Tecimer C, Demir G. Kanser hastalar\u0131nda periferik santral ven\u00f6z port komplikasyonlar\u0131. 3. T\u0131bbi Onkoloji Kongresi, 24-28 Mart 2010, Antalya. Bildiri Kitab\u0131 2010; sayfa 144-5.
\n20- Okutur K, Ba\u015fs\u00fcl\u00fc N, Ayd\u0131n K, Bozkurt M, Namal E, \u00d6zt\u00fcrk A, Tecimer C, Mandel NM, Calay Z, Ak\u00e7al\u0131 Z, Do\u011fusoy GB, Demir G. Her 2 pozitif metastatik meme kanserinde Pten, P 27 ve PI3K ekspresyonunun prediktif ve prognostik \u00f6nemi. 19. Ulusal Kanser Kongresi, 20-24 Nisan 2011, Antalya. Bildiri Kitab\u0131 2011; sayfa 15.
\n21- Ba\u015faran G, Sa\u011flam S, Tansan S, Demirel M, G\u00f6kmen E, Aktan S, G\u00f6ker E, Kaban K, Saip P, Demir G, Bavbek S, Mandel N, Tecimer C, Turhal S, Garipo\u011flu M. Hormon resept\u00f6r pozitif t\u00fcm\u00f6rl\u00fc erken evre meme kanseri hastalar\u0131nda 21-genlik rek\u00fcrrens skorun tedavi karar\u0131 \u00fczerinde etkisi: \u00c7ok merkezli retrospektif de\u011ferlendirme. 19. Ulusal Kanser Kongresi, 20-24 Nisan 2011, Antalya. Bildiri Kitab\u0131 2011; sayfa 58.
\n22- Okutur K, Ba\u015fs\u00fcl\u00fc N, Ayd\u0131n K, Bozkurt M, Namal E, Tecimer C, Mandel NM, Ak\u00e7al\u0131 Z, Do\u011fusoy GB, Demir G. Her2 pozitif metastatik meme kanserinde Pten, P 27 ve PI3K ekspresyonunun prediktif ve prognostik \u00f6nemi. 21. Ulusal Patoloji Kongresi, 16-20 Kas\u0131m 2011, \u0130zmir. Bildiri Kitab\u0131 2011; sayfa 188.
\n23- Pilanc\u0131 KN, Elb\u00fcken F, G\u00f6ksel S, Okutur K, Ordu \u00c7, Tecimer C. \u0130zole multipl pankreas metastaz\u0131 saptanan renal h\u00fccreli karsinom olgusu. 20. Ulusal Kanser Kongresi, 19-23 Nisan, 2013, Antalya. Bildiri \u00d6zetleri Kitab\u0131 2013; sayfa 183.
\n24- \u0130\u011fdem \u015e, Al\u00e7o G, Ercan T, Din\u00e7er M, Sa\u011flam S, Demir G, Tecimer C, Okkan S. Lokal ileri rektum kanserinde simultane integre boost tekni\u011fi ile neoadjuvan vol\u00fcmetrik mod\u00fcle ark tedavisi: akut yan etkiler. 20. Ulusal Kanser Kongresi, 19-23 Nisan, 2013, Antalya. Bildiri \u00d6zetleri Kitab\u0131 2013; sayfa 152.
\n25- Okutur K, Pilanc\u0131 KN, Elb\u00fcken F, Ordu \u00c7, Balc\u0131 C, Atu\u011f F, Erdem L, Sa\u011flam S, Tecimer C, Demir G. Atipik intraabdominal metastazla seyreden bir meme kanseri olgusu. 20. Ulusal Kanser Kongresi, 19-23 Nisan, 2013, Antalya. Bildiri \u00d6zetleri Kitab\u0131 2013; sayfa 118-9.
\n26- Al\u00e7o G, \u0130\u011fdem \u015e, Din\u00e7er M, \u00d6zmen V, Demir G, K\u00f6ksal G, Tecimer C, Sa\u011flam S, Pilanc\u0131 KN, Yenice S, Tuzlal\u0131 S, Erdo\u011fan Z, Uysal F, Selamo\u011flu D, \u00d6za\u00e7mak \u0130D, Bozda\u011fan A, Okkan S. Meme kanseri tedavisi g\u00f6ren olgular\u0131m\u0131zda D vitamini eksikli\u011fi. 20. Ulusal Kanser Kongresi, 19-23 Nisan, 2013, Antalya. Bildiri \u00d6zetleri Kitab\u0131 2013; sayfa 73-4.
\n27- Okutur K, Ordu \u00c7, Pilanc\u0131 KN, Ayd\u0131n K, Bozkurt M, Namal E, \u00d6zt\u00fcrk A, Sa\u011flam S, Tecimer C, Demir G. Parotis t\u00fcm\u00f6rlerinde hedefli tedavilerin etkinli\u011fine dair iki olgu. 20. Ulusal Kanser Kongresi, 19-23 Nisan, 2013, Antalya. Bildiri \u00d6zetleri Kitab\u0131 2013; sayfa 248-9.
\n28- Ordu \u00c7, Pilanc\u0131 KN, Avc\u0131 N, Okutur K, Al\u00e7o G, Demirhan \u00d6, K\u00f6ksal \u00dc, Sa\u011flam S, Tecimer C, Demir G. \u0130ki farkl\u0131 sunitinib \u015femas\u0131 tedavisi alan metastatik b\u00f6brek h\u00fccreli karsinomlu olgular\u0131n retrospektif de\u011ferlendirmesi. \u0130stanbul Bilim \u00dcniversitesi 5. Onkoloji G\u00fcnleri, 20-22 Aral\u0131k 2013, Sapanca. Bildiri \u00d6zetleri CD\u2019si.<\/p>\n

6. Kitap B\u00f6l\u00fcmleri<\/strong><\/p>\n

1- Tecimer C. Anafilaksi. \u0130li\u00e7in G, \u00dcnal S, Bibero\u011flu K, Akal\u0131n S, S\u00fcleymanlar G. (Ed.) Temel \u0130\u00e7 Hastal\u0131klar\u0131, G\u00fcne\u015f Kitabevi, Ankara, 1996, 1859-62.
\n2- Tecimer C. Ba\u015f-Boyun Cildinin Melanom D\u0131\u015f\u0131 Kanserleri- Kemoterapi ve Biyolojik Tedavi. Engin K, Eri\u015fen L.(Ed.) Ba\u015f-Boyun Kanserleri, Nobel T\u0131p Kitabevleri, \u0130stanbul, 2003, 599-602.
\n3- Tecimer C, \u00dcskent N. AIDS ile \u0130li\u015fkili T\u00fcm\u00f6rler. Ayd\u0131ner A, Topuz E. (Ed.) Onkoloji El Kitab\u0131, Astra Zeneca \u0130la\u00e7 San. ve Tic. Ltd. \u015eti. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e., \u0130stanbul, 2006, 520-30.
\n4- \u00dcskent N, Tecimer C. Akut L\u00f6semiler. Ayd\u0131ner A, Topuz E. (Ed.) Onkoloji El Kitab\u0131, Astra Zeneca \u0130la\u00e7 San. ve Tic. Ltd. \u015eti. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e., \u0130stanbul, 2006, 531-49.
\n5- \u00dcskent N, Tecimer C. Kronik Miyelositer L\u00f6semi. Ayd\u0131ner A, Topuz E. (Ed.) Onkoloji El Kitab\u0131, Astra Zeneca \u0130la\u00e7 San. ve Tic. Ltd. \u015eti. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e., \u0130stanbul, 2006, 550-7.
\n6- \u00dcskent N, Tecimer C. Kronik Lenfositik L\u00f6semi. Ayd\u0131ner A, Topuz E. (Ed.) Onkoloji El Kitab\u0131, Astra Zeneca \u0130la\u00e7 San. ve Tic. Ltd. \u015eti. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e., \u0130stanbul, 2006, 558-68.
\n7- \u00dcskent N, Tecimer C. Hodgkin Lenfoma. Ayd\u0131ner A, Topuz E. (Ed.) Onkoloji El Kitab\u0131, Astra Zeneca \u0130la\u00e7 San. ve Tic. Ltd. \u015eti. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e., \u0130stanbul, 2006, 569-86.
\n8- \u00dcskent N, Tecimer C, K\u0131nay M. Hodgkin D\u0131\u015f\u0131 Lenfomalar. Ayd\u0131ner A, Topuz E. (Ed.) Onkoloji El Kitab\u0131, Astra Zeneca \u0130la\u00e7 San. ve Tic. Ltd. \u015eti. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e. \u0130stanbul, 2006, 587-614.
\n9- \u00dcskent N, Tecimer C. Miyeloproliferatif Hastal\u0131klar. Ayd\u0131ner A, Topuz E. (Ed.) Onkoloji El Kitab\u0131, Astra Zeneca \u0130la\u00e7 San. ve Tic. Ltd. \u015eti. Turgut Yay\u0131nc\u0131l\u0131k A.\u015e., \u0130stanbul, 2006, 637-45.
\n10- Tecimer C. Kanser ve Anjiyogenez. Erol \u00c7. (Ed.) \u0130\u00e7 Hastal\u0131klar\u0131, MN Medikal ve Nobel, Ankara, 2008, 271-5.
\n11- Tecimer C. Kanser Hastas\u0131nda Hematolojik Sorunlar. Onat H, Mandel NM. (Ed.) Kanser Hastas\u0131na Yakla\u015f\u0131m, Tan\u0131, Tedavi, Takipte Sorunlar, Yenilenmi\u015f 2. Bask\u0131, Nobel T\u0131p Kitabevleri, \u0130stanbul, 2012, 137-45.<\/p>\n

\u0130dari G\u00f6revler<\/strong><\/p>\n

1- 1991-1993 \u0130n\u00f6n\u00fc \u00dcniversitesi T\u0131p Fak\u00fcltesi D\u00f6nem 4 Koordinat\u00f6rl\u00fc\u011f\u00fc
\n2- 1991- 1993 \u0130n\u00f6n\u00fc \u00dcniversitesi T\u0131p Fak\u00fcltesi \u0130\u00e7 Hastal\u0131klar\u0131 Anabilim Dal\u0131 Ba\u015fkan\u0131, Dahili T\u0131p Bilimleri B\u00f6l\u00fcm Ba\u015fkan Vekilli\u011fi
\n3- 10 \/ 8 \/ 2006 \u2013 30 \/ 4 \/ 2010 \u0130stanbul Bilim \u00dcniversitesi T\u0131bbi Onkoloji Bilim Dal\u0131 Ba\u015fkanl\u0131\u011f\u0131<\/p>\n

Bilimsel ve Mesleki Kurulu\u015flara \u00dcyelikler<\/strong><\/p>\n

1- T\u0131bbi Onkoloji Derne\u011fi
\n2- T\u00fcrk Onkoloji Grubu Derne\u011fi
\n3- T\u00fcrk Hematoloji Derne\u011fi
\n4- American Society of Clinical Oncology
\n5- European Society of Medical Oncology
\n6- Akci\u011fer Kanseri Derne\u011fi
\n7- T\u00fcrk Tabipleri Birli\u011fi \u0130stanbul Tabip Odas\u0131<\/p>\n

\u00d6d\u00fcller<\/strong><\/p>\n

1- T\u00dcB\u0130TAK Bilim Adam\u0131 Yeti\u015ftirme Grubundan Kar\u015f\u0131l\u0131ks\u0131z Destek Bursu 1972-1974 Lise ve 1974-1981 T\u0131p Fak\u00fcltesi \u00d6\u011fretim Hayat\u0131 boyunca.
\n2- 1973 y\u0131l\u0131 \u00dcniversiteleraras\u0131 Giri\u015f S\u0131nav\u0131nda T\u00fcrkiye 11.li\u011fi.
\n3- USMLE 1 ve 2 S\u0131navlar\u0131n\u0131 kazan\u0131p ECFMG Sertifikas\u0131 alarak ABD\u2019de fellow olarak \u00e7al\u0131\u015fma hakk\u0131n\u0131 elde etme ve Louisville \u00dcniversitesi\u2019nde 3 y\u0131l resmi Hematoloji\/Onkoloji fellow\u2019u olarak \u00e7al\u0131\u015fma.
\n4- Finlandiya H\u00fck\u00fcmeti Bursu ile Kuopio \u00dcniversitesi\u2019nde 1990 y\u0131l\u0131nda Hematoloji e\u011fitimi.<\/p>\n

Bilimsel Toplant\u0131 Se\u00e7ici Kurul \u00dcyelikleri<\/strong><\/p>\n

1- \u0130stanbul Meme Kanseri Konferans\u0131 18-20 Eyl\u00fcl 2003, The Marmara Oteli, \u0130stanbul
\n2- Onkolojide Yeni Ufuklar 19-21 Aral\u0131k 2003, Grand Yaz\u0131c\u0131 Otel, Uluda\u011f, Bursa
\n3- 1. Ulusal Akci\u011fer Kanseri Kongresi 25-28 Kas\u0131m 2004, \u0130stanbul
\n4- 17. Ulusal Kanser Kongresi 19-23 Nisan 2007, Antalya
\n5- \u0130stanbul Meme Kanseri Konferans\u0131 ve Ulusal Meme Kanseri Konsensus Toplant\u0131s\u0131, 21-25 Ekim 2008, \u0130stanbul
\n6- 4. \u0130stanbul Meme Kanseri Konferans\u0131, 15-17 Nisan 2010, \u0130stanbul
\n7- 4. T\u0131bbi Onkoloji Kongresi, 21-25 Mart 2012, Antalya
\n8- 3. Ulusal Lenfoma-Myeloma Kongresi, 10-13 May\u0131s 2012, Antalya.<\/p>\n

Son iki y\u0131lda verilen lisans ve lisans\u00fcst\u00fc d\u00fczeydeki dersler<\/strong><\/p>\n

1- 2012-2013 G\u00fcz d\u00f6nemi
\n\u0130\u00e7 Hastal\u0131klar\u0131na Giri\u015f, 1 saat teorik, yakla\u015f\u0131k 30 \u00f6\u011frenci (3. D\u00f6nem)
\nKanserden korunma ve kanser taramas\u0131, 2 saat teorik, yakla\u015f\u0131k 25 \u00f6\u011frenci (4. D\u00f6nem)
\nKanser hastas\u0131na genel yakla\u015f\u0131m, 2 saat teorik, yakla\u015f\u0131k 25 \u00f6\u011frenci (4. D\u00f6nem)
\nKanser hastas\u0131na genel yakla\u015f\u0131m, 6 saat uygulama, yakla\u015f\u0131k 25 \u00f6\u011frenci (4. D\u00f6nem)
\nDahiliye-Onkoloji servis prati\u011fi, 4 saat uygulama, yakla\u015f\u0131k 6 \u00f6\u011frenci (6. D\u00f6nem)<\/p>\n

2- 2013-2014 G\u00fcz D\u00f6nemi:
\n\u0130\u00e7 Hastal\u0131klar\u0131na Giri\u015f: Kanser tarama programlar\u0131, 1 saat teorik, yakla\u015f\u0131k 30 \u00f6\u011frenci
\n(3. D\u00f6nem)
\nKanserden korunma ve kanser taramas\u0131, 4 saat teorik, yakla\u015f\u0131k 16 \u00f6\u011frenci (4. D\u00f6nem)
\nKanser hastas\u0131na genel yakla\u015f\u0131m, 4 saat teorik, yakla\u015f\u0131k 16 \u00f6\u011frenci (4. D\u00f6nem)
\nKanser hastas\u0131na genel yakla\u015f\u0131m, 12 saat uygulama, yakla\u015f\u0131k 16 \u00f6\u011frenci (4. D\u00f6nem)
\nDahiliye-Onkoloji servis prati\u011fi, 4 saat uygulama, yakla\u015f\u0131k 4 \u00f6\u011frenci (6. D\u00f6nem)<\/p>\n

 
\n 
\n <\/p>\n","protected":false},"excerpt":{"rendered":"

1957 y\u0131l\u0131nda do\u011fdum. 1974 y\u0131l\u0131nda Ankara Mustafa Kemal Lisesini bitirdikten sonra \u00dcniversiteler Aras\u0131 Se\u00e7me S\u0131nav\u0131nda T\u00fcrkiye 11.si olarak Hacettepe T\u0131p Fak\u00fcltesi\u2019ne girdim. 1981 y\u0131l\u0131nda bu fak\u00fclteden mezun oldum. Askerlik hizmetini tamamlad\u0131ktan sonra 1983 y\u0131l\u0131nda ayn\u0131 fak\u00fcltenin \u0130\u00e7 Hastal\u0131klar\u0131 Ana Bilim Dal\u0131\u2019na ara\u015ft\u0131rma g\u00f6revlisi olarak girdim. 1987 y\u0131l\u0131nda \u0130\u00e7 Hastal\u0131klar\u0131 uzman\u0131 \u2026<\/p>\n

Devam\u0131n\u0131 Oku<\/i><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"templates\/template-onecolumn.php","meta":[],"_links":{"self":[{"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/pages\/10"}],"collection":[{"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/comments?post=10"}],"version-history":[{"count":14,"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/pages\/10\/revisions"}],"predecessor-version":[{"id":718,"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/pages\/10\/revisions\/718"}],"wp:attachment":[{"href":"https:\/\/coskuntecimer.com\/t\/wp-json\/wp\/v2\/media?parent=10"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}